>>> Europe : Brokers Upgrades & Downgrades - 13th of February 2025

>>> Up
* Anora Group Oyj Raised to Accumulate at Inderes; PT 3.30 euros
* Avanza Raised to Overweight at Morgan Stanley; PT 370 kronor
* BCP Raised to Outperform at Mediobanca SpA; PT 59 euro cents
* Bellway Raised to Add at Peel Hunt; PT 3,000 pence
* Cytokinetics Raised to Overweight at Morgan Stanley; PT $67
* flatexDEGIRO Raised to Overweight at Morgan Stanley; PT 21 euros
* HubSpot Raised to Overweight at KeyBanc; PT $920
* Kempower Raised to Accumulate at Inderes; PT 13 euros
* Lime Technologies Raised to Buy at Pareto Securities
* Lime Technologies Raised to Buy at SEB Equities; PT 410 kronor
* DuPont de Nemours Raised to Equal-Weight at Barclays; PT $89
* Gilead Raised to Buy at DZ Bank; PT $108
* Pihlajalinna Raised to Buy at Inderes; PT 13.50 euros
* Porsche SE Raised to Hold at HSBC; PT 35 euros
* SSAB Raised to Buy at Nordea; PT 68 kronor
* STMicro Raised to Equal-Weight at Morgan Stanley; PT 22 euros
* VW Raised to Buy at HSBC; PT 125 euros
* WDP Raised to Equal-Weight at Morgan Stanley; PT 25 euros

>>> Down
* Banco BPM Cut to Neutral at Mediobanca SpA; PT 8.90 euros
* Biogen PT Cut to $144 from $175 at Stifel
* Celanese Cut to Junk by Moody’s as Prices, Volume Fall
* Entra Cut to Hold at ABG; PT 118 kroner
* Kering Cut to Sell at DZ Bank; PT 238 euros
* Medicover Cut to Hold at Deutsche Bank; PT 215 kronor
* Porsche Cut to Hold at HSBC; PT 60 euros
* Springvest Cut to Reduce at Inderes; PT 8.50 euros
* Volvo Car Cut to Hold at HSBC; PT 22 kronor

>>> Initiation
* Airtel Africa Reinstated Buy at SBG Securities; PT 134 pence
* doValue Rated New Buy at Stifel; PT 2.85 euros
* eDreams ODIGEO Rated New Market Perform at Bernstein
* GE Vernova Rated New Outperform at Baird; PT $448
* Viking Therapeutics Rated New Sector Outperform at Scotiabank
* WAG Payment Rated New Buy at Investec; PT 112 pence

>>> Call
* Saipem Strategy Update May Present Buying Opportunity, Citi Says

>>> What to look at today - 13th of February 2025

Asian equities rose as US-Russia talks spurred expectations for an end to the war in Ukraine. Risk sentiment was also stoked by the improving prospects for Chinese markets.  A gauge of equities in Asia climbed for a second day, led by shares in Japan and Hong Kong. European stock index futures gained about 1% and S&P 500 contracts also advanced. Global markets looked past the higher-than-expected US inflation figures — which eroded bets on rate cuts — with traders focusing on US President Donald Trump’s Ukraine peace talks with Russia. The euro rose versus most of its Group-of-10 peers, strengthening 0.5% against the dollar.  The upswing in risk appetite came after the Asian regional stock gauge underperformed its global peers so far this year as Trump’s tariff threats, a stronger dollar and China’s lack of domestic policy stimulus weighed on the market. Chinese equities though have been lifted in recent weeks by an artificial intelligence breakthrough. The dollar weakened against all G-10 currencies as prospects for an end to the war in Ukraine damped demand for haven assets. The Scandinavian and European currencies led the rally against the greenback. Oil extended declines after the US-Russia talks, raising speculation that risks to Russian supply may ease. Shares of aluminum producer United Co Rusal International PJSC jumped as much as 29% in Hong Kong, the biggest gain in almost three years. Asian shipping stocks fell on concern freight rates may drop.  Market sentiment got a boost from “the potential resolution of the Russia-Ukraine conflict, and the ongoing momentum in China’s tech sector,” said Charu Chanana, chief investment strategist for Saxo Markets Pte in Singapore.  Yields on 10-year US Treasuries edged down after jumping on Wednesday. Trump agreed in a phone call with Russian President Vladimir Putin to start negotiating an end to the war in Ukraine, sweeping aside three years of US policy and blindsiding European allies who feared the more conciliatory American stance amounted to a giveaway to the Russian leader. Traders’ rush to buy Chinese technology stocks for their artificial intelligence potential has put the Hang Seng Tech Index on course for its highest close since the nation’s Covid-era reopening rally. The frenzy over Chinese artificial intelligence is turning Alibaba Group Holding Ltd. into an investor favorite again with its Hong Kong-listed shares surging 46% since hitting a 2025 low on Jan. 13. On Wednesday, Treasuries fell across the curve as investors adjusted expectations for Fed cuts following the inflation reading. The moves were mainly centered upon the higher-than-expected rise in US prices, which led traders to adjust bets on US rate cuts to now project the first and only reduction this year to come in December. Gold held a rally from its previous session, inching back toward its record high achieved earlier this week. US After Hours CSCO +6.8%, APP +27.7%, BROS +24.2%, HOOD +16%, MGM +10.8% higher on earnings; ASPN -35%, TTD -27.3%, FSLY -20.7%, RDDT -16.2% lower on earnings

Nikkei +1.28% Hang Seng +1.89% CSI -0.14% Shanghai -0.20% Shenzen -0.50%

Eur$ 1.0426 CNH 7.2921 CNY 7.2911 JPY 154.04 GBP 1.2490 CHF 0.9112 RUB 93.0081 +1.07% TRY 36.1115 WTI$ 70.70 -0.94% Gold 2,916 +0.41% BTC 96,000 -1.70% ETH 6,685 +0.07%

S&P +0.21% Nasdaq +0.43% EuroStoxx +0.98% FTSE +0.15% Dax +1.07% SMI

Macro :
- Secretive Hedge Fund QRT Storms $4.5 Trillion Industry’s Elite
- Qatar Wealth Fund Backs London-Based Venture Capital Firm Utopia

Keep an eye on :
- ADYEN NA : Adyen 2H Net Revenue Beats Estimates (2)
- ALFEN NA : Alfen 2025 Revenue Forecast Misses Estimates
- ARCAD NA : Arcadis 4Q Net Revenue EU959M Vs. EU941M Y/y
- ARGEO NO : Argeo Offers Up to NOK96 million Shares
- BAMNB NA : BAM Sees 2025 Adjusted Ebitda Margin About 5%
- BAS GY : BASF Said to Ask Banks to Pitch for Agri Chemicals Unit Listing
- BDT GY : Bertrandt 1Q Ebit Loss EU2.14B Vs. Profit EU13.5M Y/y
- BCVN SW : BC Vaudoise FY Net Income CHF441M
- BELL SW : Bell FY Ebitda Meets Estimates
- BNP FP : BNP Paribas, BPCE to Create Payment Processing JV: Les Echos
- BA US : Trump Says ‘Not Happy’ With Boeing Plane ‘Service We’re Getting’
- CE US : Celanese Cut to Junk by Moody’s on Slow Global Demand Recovery
- CRI FP : Chargeurs FY Ebitda Beats Estimates
- CBG LN : Close Brothers Sees £165 Million Provision for Car-Loan Saga (2)
- CBK GY ; Commerzbank Sees 2025 Net Profit of €2.4B After Restructuring (1)
- ACA FP : Credit Agricole Italia Board Proposes Hugues Brasseur as CEO
- DEME BB : DEME Doesn’t Know Why Argentina River Dredging Auction Failed
- DSFIR NA : DSM-Firmenich 4Q Adjusted Ebitda Beats Estimates
- FGR FP : Eiffage Consortium Wins Bordeaux University Hospital Contract
- EMBRACB SS : Embracer 3Q Net Sales SEK7.36B
- EL FP : EssilorLuxottica Sales Beat Estimates on Ray-Ban Meta, Supreme
- Ferrari Group IPO : Ferrari Group IPO Priced at €8.60/Share, Terms Show
- FLOW NA : Flow Traders 4Q Net Trading Income Beats Estimates
- FRA GY : Fraport Jan. Frankfurt Airport Passengers -3.1%
- GMAB DC : Genmab Sees 2025 Revenue of $3.34b to $3.66b (1)
- HFG GY : Hellofresh Top Shareholder Wants Up to €560m in Cost Cuts: WiWo
- HTG GY : HomeToGo Offers 53.1m Shares at EU1.60/Share: Terms
- HUBS US : HubSpot 1Q Adjusted EPS Forecast Misses Estimates
- IPN FP : Ipsen FY Core Operating Profit Beats Estimates
- KBC BB : KBC Sees 2025 Net Interest Income at Least EU5.7B, Est. EU5.62B
- LI FP : Klepierre Sees 2025 Group NCCF/Shr EU2.60 to EU2.65
- LR FP : Legrand FY Adjusted Operating Profit Beats Estimates
- MANTA FH : Mandatum 4Q Pretax Profit Beats Estimates
- MEKO SS : Meko 4Q Ebit SEK127M Vs. SEK68M Y/y
- MERY FP : Mercialys FY Recurring Net Income Meets Estimates
- ML FP : Michelin FY Total Segment Operating Income Beats Estimates, Michelin Sees Tough Tire Market Persisting on Muted Auto Demand
- Novo banco : Novo Banco to Start Procedure for Initial Public Offering
- ORA FP : Orange’s Sales Meet Analysts’ Estimates on Growth in Africa
- PCELL SS : PowerCell 4Q Sales SEK144.1M Vs. SEK127.5M Y/y
- QTCOM FH : QT Group Sees 2025 Net Sales +15% to +25%
- RAIVV FH : Raisio 4Q Adjusted EPS Matches Estimates
- RNO FP : Honda, Nissan Officially Call Off Talks to Combine (1)
- ROG SW : Roche’s Genentech’s Evrysdi Tablet for SMA Gets FDA Approval
- NAS NO : Norwegian Air 4Q Ebit Loss NOK93.2M, Est. Profit NOK171.5M
- NESN SW : Nestle Sees 2025 Underlying Trading Oper Margin at Least 16% (1)
- NOKIA FH: Taiwan FTC Approves Nokia’s Acquisition of Infinera
- SAVE SS : Nordnet Says 1,500 Customers Hit by Security Breach, DI Reports
- ORK NO :
- RXL FP : Rexel Sees 2025 Adjusted Ebita Margin About 6%
- SAN FP : Sanofi Ends E. Coli Vaccine Study, Records $250M Hit in 4Q24
- SINCH SS : Sinch Records SEK700m One-Time Provision After Tax Revision
- SCMN Sw : Swisscom FY Net Revenue Meets Estimates, Swisscom Sees 2025 Net Revenue About CHF15.0B to CHF15.2B
- STR AV : Strabag Sees 2025 Ebit Margin at Least 4.5%, Output at €21b (1)
- SIE GY : Siemens 1Q Industrial Business Profit Beats Estimates
- STORB SS : Storskogen 4Q Sales Miss Estimates
- TTK GY : Takkt Proposes €0.60/Shr Div., Reached Upper End of FY24 Goals
- TIT IM : Telecom Italia 4Q Organic Revenue Meets Estimates
- TFI FP : TF1 FY Current Operating Income Beats Estimates
- TKA GY : Thyssenkrupp 1Q Adjusted Ebit Beats Estimates, Thyssenkrupp Raises Guidance After Major Naval Order Payment
- UCG IM : *DELFIN CHAIR TO SOLE: NO DECISION ON UNICREDIT STAKE
- X US : Nippon Steel Meeting With Trump Seen Next Week or Later: Asahi
- URW FP : Unibail 2025 Adjusted Recurring EPS Forecast Misses Estimates
- VEI NO : Veidekke 4Q Revenue Meets Estimates
- VIMIAN SS : Vimian 4Q Revenue Beats Estimates
- VOW GY : VW, Audi Consider Extending Combustion Engine Models to 2035: HB
- WIE AV : Wienerberger Says Will Buy Back 1%-2% of Share Capital Annually

FT : Buyout group Thoma Bravo set for $4bn windfall after SailPoint IPO

Buyout group Thoma Bravo set for $4bn windfall after SailPoint IPO
Bankers expect flurry of listings on back of buoyant stock markets and easing financial conditions

Cybersecurity specialist SailPoint’s initial public offering is poised to hand investors a multibillion-dollar windfall from a private equity deal struck at the height of a record wave of takeovers in 2021 and 2022.

US private equity group Thoma Bravo stands to make more than $4bn from the IPO, which is expected to value the Texas-based company at more than $12bn.

The sum would represent a large paper gain from a takeover many private equity investors had worried was struck at a sky-high valuation that would be weighed down by falling tech valuations.

Thoma Bravo paid $6.9bn for SailPoint in April 2022, about 15 times annual sales for a company that was barely profitable at the time.

Fears about the deal’s lofty valuation were accentuated by surging inflation in 2022 that forced the Federal Reserve to raise interest rates to more than 5 per cent.

The markedly different environment wreaked havoc on the private equity industry, which has returned minimal amounts of cash to its investors in recent years as markets for new listings have seized up and merger activity has slowed.

Many analysts expected private equity groups such as Thoma Bravo, which manages $160bn in assets and was among the most active dealmakers in 2021, would be forced to hold their investments for longer to justify their purchase price. SailPoint’s annualised recurring revenues have roughly doubled to more than $800mn since Thoma Bravo’s buyout, according to filings.

Thoma Bravo used about $6bn of its investors’ cash to buy SailPoint. In December 2024, it invested a further $600mn to pay down SailPoint’s debt in an effort to increase the company’s appeal to shareholders. The deal raised Thoma Bravo’s overall equity investment to $6.6bn.

SailPoint stock is being offered to investors at $23 a share, according to Bloomberg, up from a range of $19 to $21. At SailPoint’s new price range, Thoma Bravo’s gains stand to be more than $4bn.

However, since it is not selling stock as part of the offering, the windfall has not been realised and will be exposed to SailPoint’s performance on public markets.

SailPoint will use proceeds of more than $1bn to repay virtually all of its outstanding debt. The IPO has attracted anchor investors Dragoneer Investment Group and AllianceBernstein, which will purchase about 20 per cent of the offering. 

Buoyant stock markets and easing financial conditions mean bankers expect a flurry of listings in the coming months, driven in part by private equity groups looking to offload some of their biggest holdings acquired when interest rates were close to zero.

But the year has begun slowly for dealmaking and IPOs. Shares in US liquid natural gas exporter Venture Global, for instance, are down almost 40 per cent since the company’s debut in mid-January.

SailPoint’s IPO is being closely watched as a useful gauge of investor appetite for tech listings after DeepSeek’s cut-price artificial intelligence breakthrough stunned markets last month.

“Everyone was expecting the market to be fabulous under a Republican administration, but it hasn’t gone to plan so far,” said a person close to the IPO for space and defence contractor Karman Holdings, which is also expected to start trading this week.

Karman has set a valuation range of $18 to $20 a share for a $400mn IPO, implying a fully diluted market capitalisation of $2.5bn.

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • UPST +27%, MCY +22.8%, CFLT +13.8% (also announces strategic partnership with jio platforms), SMCI +10.1% (also delays 10-Q filing; in late 2024, received subpoenas from DOJ and SEC; also $700 mln private placement of convertible notes), CVS +9.8%, IVT +9.4%, PBI +8.7% (also names new CFO), UFCS +8.2%, RDWR +7.4%, MLYS +7.1%, FRSH +6.9%, ELMD +6.2%, DASH +6.1%, LAD +6.1%, TMHC +5.8%, MIR +5.1%, HIW +5%, PAX +4.7%, ANGI +4.6%, EW +4.5%, GILD +4.4% (also increases dividend), CAMT +4.1%, IAC +3.9%, BHF +3.7%, QSR +3.6%, AKR +3.5% (also increases dividend), CRSP +3.4%, GNRC +3.4%, HIVE +3.3%, ALKS +3.2%, HCSG +3.1%, BAM +3%, CHEF +2.9%, SPTN +2.9%, BVN +2.7%, RRR +2.1%, CME +2%, THC +1.9%, MRC +1.8%, COOP +1.7%, ST +1.6%, ECG +1.4%, DENN +1.3%, PAL +1.2%, GOLD +1.2%, ADC +1%, NI +1%,
Other news:
  • ANAB +37.4% (to announce phase 2b trial data of Rosnilimab)
  • RDFN +5.4% (announces content license agreement and partnership agreement with Zillow)
  • SWTX +3.4% (confirms that the FDA has approved GOMEKLI for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas)
  • VLN +2.9% (authorizes new $15 mln share repurchase program)
  • MXCT +2.9% (enters strategic platform license with TG Therapeutics) HP +2.7% (CEO and a Director bought 57,356 shares worth nearly $1.6 mln)
  • LTBR +2.6% (announces a significant milestone in its innovative nuclear fuel development efforts)
  • RDDT +2.4% (ICE and RDDT announce data analytics partnership)
  • POET +1.8% (provides business update)
  • WAFD +1.6% (increases dividend)
  • CPA +1.1% (reports Jan traffic)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • STAA -36.7%, SMWB -25.9%, OS -17.5%, LYFT -13.6%, BL -13.4%, TDC -13.4% (also CFO to step down), VRT -8.7%, ZG -6.6% (also announces content and license partnership with RDFN), ALSN -6.3%, VPG -5.9%, WAB -5.8%, WAT -5%, KHC -3.9%, SW -3.7%, SLVM -3.4%, CIM -3.2%, MLM -3.2%, PAMT -2.1%, CAR -1.9%, MCRI -1.9%, DBD -1.7%, ET -1.6%, SAGE -1.1%, ADPT -1%, BXMT -1%
Other news:
  • SPIR -52.4% (discloses substantial doubt about ability to continue as a going concern)
  • ZWS -3.8% (prices offering by selling shareholder of 7.75 mln shares of common stock at $35.00 per share)
  • BCAX -3.6% (first patients enrolled in FORTIFI-HN01)
  • ULCC -3% (discloses Spirit Airlines (SAVEQ) updates)
  • BOOM -2.3% (rejected a non-binding proposal from Steel Connect to acquire all of the outstanding shares of common stock of the Company, not already owned by Steel Connect, for $10.18 per share in cash)
  • RNST -1.4% (files mixed shelf securities offering)

>>> US Research Calls II

Research Calls II
  • Upgrades:
    • EOG Resources (EOG) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $155
    • Ero Copper (ERO) upgraded to Buy from Hold at TD Cowen
    • Grupo Aeroportuario del Pacifico (PAC) upgraded to Hold from Underperform at Jefferies; tgt raised to $210
    • NXP Semi (NXPI) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $257
  • Downgrades:
    • Banco Bradesco (BBD) downgraded to Sell from Buy at Goldman; tgt lowered to $2
    • BayCom (BCML) downgraded to Market Perform from Outperform at Hovde Group; tgt $31
    • Endeavor Group (EDR) downgraded to Sell from Neutral at Seaport Research Partners; tgt $27.50
    • Fidelity Nat'l Info (FIS) downgraded to Neutral from Positive at Susquehanna; tgt lowered to $81
    • GlobalFoundries (GFS) upgraded to Buy from Hold at Needham; tgt $50
    • Inhibikase Therapeutics (IKT) downgraded to Neutral from Buy at H.C. Wainwright
    • OneStream (OS) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $26
    • Opportunity Financial (OPFI) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • TKO Group Holdings (TKO) downgraded to Neutral from Buy at Seaport Research Partners
  • Others:
    • Instacart (CART) initiated with a Buy at Seaport Research Partners; tgt $62
    • ProQR Therapeutics (PRQR) initiated with a Buy at JonesResearch
    • Transportadora de Gas del Sur (TGS) initiated with a Buy at Citigroup; tgt $35
    • Uranium Energy (UEC) initiated with an Outperform at National Bank Financial; tgt $10
    • Volaris Aviation (VLRS) initiated with an Outperform at Itau BBA; tgt $12

>>> US Research Calls III

Research Calls III
  • Upgrades:
    • Banco Santander Brasil (BSBR) upgraded to Neutral from Sell at Goldman; tgt raised to $4.70
    • Dell (DELL) upgraded to Positive from Mixed at OTR Global
    • LCI Industries (LCII) upgraded to Market Outperform from Market Perform at CJS Securities; tgt $145
  • Downgrades:
    • Hovnanian (HOV) downgraded to Underperform from Neutral at Zelman
    • Moleculin Biotech (MBRX) downgraded to Hold from Buy at Maxim Group
  • Others:
    • Essential Properties Realty Trust (EPRT) initiated with an Overweight at CapitalOne; tgt $35
    • Myriad Genetics (MYGN) initiated with a Buy at Craig Hallum; tgt $29

FT : UK trader wins fight against extradition to US on insider trading charges

UK trader wins fight against extradition to US on insider trading charges
UK Supreme Court on Wednesday quashed extradition of Joseph El-Khouri, curbing the reach of US prosecutors

The UK Supreme Court has quashed the extradition to the US of a trader accused of insider trading in an unusual decision by British judges to curb the reach of American justice.

The UK’s highest court on Wednesday ruled in favour of Joseph El-Khouri, who US prosecutors claimed netted $2mn in profits from an insider trading conspiracy.

El-Khouri, a dual British and Lebanese national who lives in the UK, was charged in New York in 2019 and accused of obtaining inside information about prospective mergers and acquisitions of New York-listed companies.

The Manhattan US attorney’s office claimed he paid an intermediary for the information in cash and gifts including a yacht in Greece, a chalet in France and a hotel room in New York, and traded “contracts for difference” through a UK broker.

El-Khouri resisted extradition and accused the American authorities of over-reach, arguing that any links to the US were tenuous as the alleged misconduct took place in London.

A lower court had previously allowed his extradition after a hearing in 2021 and the UK government ordered that El-Khouri be sent to the US. An initial appeal by the trader at the High Court in London failed.

But a panel of five senior judges, led by the Supreme Court president Lord Robert Reed, on Wednesday unanimously ruled in his favour, blocking his removal on the grounds that the alleged criminality occurred outside the US.

The court noted that the UK’s Financial Conduct Authority conducted an investigation into El-Khouri between November 2016 and January 2018 but had concluded there was insufficient evidence to prosecute him.

El-Khouri’s lawyer, Richard Cannon of Stokoe Partnership Solicitors, said the ruling “brings to an end a five-and-a-half-year nightmare” that began with his arrest in 2019.

He added that the decision “represents an important check on over-reach” by the US authorities.

The US state department in London did not immediately respond to a request for comment.